SE0002551D0 - Screening methods - Google Patents

Screening methods

Info

Publication number
SE0002551D0
SE0002551D0 SE0002551A SE0002551A SE0002551D0 SE 0002551 D0 SE0002551 D0 SE 0002551D0 SE 0002551 A SE0002551 A SE 0002551A SE 0002551 A SE0002551 A SE 0002551A SE 0002551 D0 SE0002551 D0 SE 0002551D0
Authority
SE
Sweden
Prior art keywords
screening methods
angiogenesis
relates
tumor progression
useful
Prior art date
Application number
SE0002551A
Other languages
English (en)
Swedish (sv)
Inventor
Anders Berkenstam
Lorenz Poellinger
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE0002551A priority Critical patent/SE0002551D0/xx
Publication of SE0002551D0 publication Critical patent/SE0002551D0/xx
Priority to DE60122167T priority patent/DE60122167D1/de
Priority to PCT/SE2001/001387 priority patent/WO2002002609A1/fr
Priority to EP01941415A priority patent/EP1307481B1/fr
Priority to JP2002507861A priority patent/JP2004502416A/ja
Priority to CA002414995A priority patent/CA2414995A1/fr
Priority to AU2001274772A priority patent/AU2001274772B2/en
Priority to AU7477201A priority patent/AU7477201A/xx
Priority to AT01941415T priority patent/ATE335762T1/de
Priority to CN01812424A priority patent/CN1461309A/zh
Priority to US09/896,791 priority patent/US7214770B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE0002551A 2000-07-06 2000-07-06 Screening methods SE0002551D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE0002551A SE0002551D0 (sv) 2000-07-06 2000-07-06 Screening methods
CN01812424A CN1461309A (zh) 2000-07-06 2001-06-19 抑制性pas结构域蛋白(ipas)以及与血管形成和肿瘤进程有关的筛选方法
JP2002507861A JP2004502416A (ja) 2000-07-06 2001-06-19 血管新生および腫瘍進行に関連する抑制性ｐａｓドメインタンパク質（ｉｐａｓ）およびスクリーニング法
PCT/SE2001/001387 WO2002002609A1 (fr) 2000-07-06 2001-06-19 Proteine inhibitrice du domaine pas (ipas) et methodes de criblage relatives a l'angiogenese et a la progression d'une tumeur
EP01941415A EP1307481B1 (fr) 2000-07-06 2001-06-19 Proteine inhibitrice du domaine pas (ipas) et methodes de criblage relatives a l'angiogenese et a la progression d'une tumeur
DE60122167T DE60122167D1 (de) 2000-07-06 2001-06-19 INHIBITORISCHES PAS-DOMäNEN PROTEIN (IPAS) UND ANGIOGENESE UND TUMORWACHSTUM BEZOGENE SCREENING-METHODEN
CA002414995A CA2414995A1 (fr) 2000-07-06 2001-06-19 Proteine inhibitrice du domaine pas (ipas) et methodes de criblage relatives a l'angiogenese et a la progression d'une tumeur
AU2001274772A AU2001274772B2 (en) 2000-07-06 2001-06-19 Inhibitory PAS domain protein (IPAS) and screening methods related to angiogenesis and tumor progression
AU7477201A AU7477201A (en) 2000-07-06 2001-06-19 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression
AT01941415T ATE335762T1 (de) 2000-07-06 2001-06-19 Inhibitorisches pas-domänen protein (ipas) und angiogenese und tumorwachstum bezogene screening- methoden
US09/896,791 US7214770B2 (en) 2000-07-06 2001-06-29 Screening Methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0002551A SE0002551D0 (sv) 2000-07-06 2000-07-06 Screening methods

Publications (1)

Publication Number Publication Date
SE0002551D0 true SE0002551D0 (sv) 2000-07-06

Family

ID=20280392

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002551A SE0002551D0 (sv) 2000-07-06 2000-07-06 Screening methods

Country Status (9)

Country Link
EP (1) EP1307481B1 (fr)
JP (1) JP2004502416A (fr)
CN (1) CN1461309A (fr)
AT (1) ATE335762T1 (fr)
AU (2) AU7477201A (fr)
CA (1) CA2414995A1 (fr)
DE (1) DE60122167D1 (fr)
SE (1) SE0002551D0 (fr)
WO (1) WO2002002609A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002231223A1 (en) 2000-10-26 2002-05-06 The Brigham And Women's Hospital, Inc. Compositions and methods for treating hematologic malignancies and multiple drug resistance
WO2003045440A1 (fr) * 2001-11-28 2003-06-05 Angiogenetics Sweden Ab Regulation de l'expression d'un gene inductible par hypoxie au moyen de la proteine de domaine pas inhibiteur antisens
GB2384428A (en) * 2002-01-29 2003-07-30 Thromb X Nv Inhibitors of HIF
WO2011156380A2 (fr) 2010-06-07 2011-12-15 Biopolymer Technologies, Ltd. Adhésifs à base de protéines, et procédés de fabrication et d'utilisation de ces adhésifs
JP2012072063A (ja) * 2010-09-27 2012-04-12 Japan Health Science Foundation 細胞の造腫瘍性試験方法及び腫瘍マーカー
BR112014005502A2 (pt) 2011-09-09 2017-04-04 Biopolymer Tech Ltd adesivos contendo proteínas, e fabricação e uso dos mesmos
EP3666845A1 (fr) 2012-07-30 2020-06-17 Evertree Adhésifs de protéine contenant un anhydride, de l'acide carboxylique et/ou un composé de sel de carboxylate et leur utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028464A2 (fr) * 1997-11-28 1999-06-10 Wisconsin Alumni Research Foundation Adn complementaires et proteines appartenant a la superfamille bhlh-pas des regulateurs de transcription et procedes d'utilisation correspondants
JP2001525173A (ja) * 1997-12-04 2001-12-11 ジェンザイム・コーポレーション 遺伝子発現を誘導するための組成物および方法
AU5562999A (en) * 1998-08-14 2000-03-06 President And Fellows Of Harvard College Methods of modulating of angiogenesis

Also Published As

Publication number Publication date
AU2001274772B2 (en) 2006-10-05
JP2004502416A (ja) 2004-01-29
WO2002002609A1 (fr) 2002-01-10
DE60122167D1 (de) 2006-09-21
CA2414995A1 (fr) 2002-01-10
CN1461309A (zh) 2003-12-10
ATE335762T1 (de) 2006-09-15
AU7477201A (en) 2002-01-14
EP1307481A1 (fr) 2003-05-07
EP1307481B1 (fr) 2006-08-09

Similar Documents

Publication Publication Date Title
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
HK1051691A1 (en) Hydroxylstilbenes and stilbene derivatives and analogues of anti-inflammatory and psoriasis treatment and protein kinase inhibition
ATE512976T1 (de) Hemmer des hepatitis-c-virus
EA200300788A1 (ru) Производные замещенных алкиламинов и их применение
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
BR0116411A (pt) Compostos de pirazol úteis como inibidores de proteìna cinase
CY1105915T1 (el) Παραγωγα θειαζολιου για τη θepαπεια των παθησεων που σχετιζονται με τους ppar
HK1067128A1 (en) Beta-carbolin derivatives as ptp-inhibitors
CL2003001743A1 (es) Compuestos derivados de leucinamida, inhibidores de la cisteina proteasa; composicion farmaceutica; procedimiento de preparacion de la composicion farmaceutica; y su uso en el tratamiento de la osteoporosis, enfermedad de paget's, peridontal, perdida
DE60105295D1 (de) Chinazolinderivate zur behandlung von tumoren
DK0642513T3 (da) Indolcarbazolimider og deres anvendelse
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE60233261D1 (de) Inhibitoren von humanem adam-10
DK0434057T3 (da) Indocarbazol-derivater, fremgangsmåder til deres fremstilling og deres anvendelse
SE0002551D0 (sv) Screening methods
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE223376T1 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
MX9300100A (es) Peptidos hemorreguladores.
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DE60311822D1 (de) Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen
DE60209886D1 (de) Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen
EA200300059A1 (ru) Комбинированная противоопухолевая терапия, включающая применение производных замещенного акрилоилдистамицина, таксанов и/или антиметаболитов
ATE307805T1 (de) Imidazolonderivate zur behandlung viraler krankheiten